Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-01-04 @ 9:38 AM
Study NCT ID:
NCT01535157
Status:
TERMINATED
Last Update Posted:
2020-08-27
First Post:
2012-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
Sponsor:
South Plains Oncology Consortium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-03
First Submit QC Date:
None
Study First Post Date:
2012-02-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-25
Last Update Post Date:
2020-08-27
Last Update Post Date Type:
ACTUAL